Indian J Pharm Close
 

Table 5: Number and percent of patients with most frequently reported (≥ 10% of patients) treatmentemergent adverse events, by system organ class and preferred term within dose group and duration of infusion – intent-to-treat population

Table 5: Number and percent of patients with most frequently reported (≥ 10% of patients) treatmentemergent adverse events, by system organ class and preferred term within dose group and duration of infusion – intent-to-treat population